Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026
The cardiac ablation catheters market is set to grow at a CAGR of 6.15% by 2027, driven by increasing procedures and technological advancements.
Cardiac Ablation Catheters Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Cardiac Ablation Catheters Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/899
Growing catheter ablation procedures around the globe are primarily fueling growth of the cardiac ablation catheters market. According to the U.S. Department of Health & Human Services, it is estimated that 12.1 million people in the United States will have AFib in 2030. In 2018, AFib was mentioned on 175,326 death certificates and was the underlying cause of death in 25,845 of those deaths. Moreover, the rising aging population is again increasing prevalence of atrial fibrillation, atrial flutter and supraventricular tachycardia, and a decrease in heart muscle elasticity condition. This factor will also stimulate the growth of the market. According to the study by American Heart Association in 2017, catheter-based ablation procedures claim a 90% success rate with minimum risk of complications allowing patients to resume normal activities within a few days, thereby growing the demand for ablation catheters in surgical procedures.
North America is expected to hold a dominant position in the global cardiac ablation catheters market in the near future owing to the aging population which is increasing the risk of cardiac arrhythmia condition. According to the U.S. Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019.
In August 2020, Abbott announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF), a type of irregular heartbeat
In June 2020, Boston Scientific announced the U.S. launch of the DIRECTSENSE
Technology, a tool for monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures.
In January 2020, Imricor Medical Systems announced that it has won CE Mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode
Cardiac catheters and plugs have been the standard surgical method of inserting patients for more than a century. However, with the advent of new technology and medical science, cardiac catheters are fast becoming a thing of the past. Catheter ablation is an advanced surgical procedure used to eliminate or terminate an electrical pathway in various parts of the patient’s heart affected by cardiac arrhythmias such as atrial fibrillar spasm, atrial tachycardia, ventricular fibrillation, and Wolff-Rankin syndrome. The procedure is also known by other names such as coronary artery dilation or PCI, and ventricular tachycardia using a catheter. It is often combined with other surgical procedures in order to maximize the patient’s outcome and minimize complications.
Top Key Players Include In Cardiac Ablation Catheters Market: Medtronic, St. Jude Medical, Boston Scientific and Biosense Webste
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/899
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Cardiac Ablation Catheters Market Records a CAGR of 6.15% by 2027|COVID-19 Impact Analysis appeared first on Gatorledger.
The article discusses the growth and trends in the cardiac ablation catheters market.
The market is projected to grow at a CAGR of 6.15% by 2027.
Key players include Medtronic, St. Jude Medical, and Boston Scientific.
Explore more articles in the Research Reports category
